Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing

Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing

The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.

Gilead reveals plans to put another $11B into US manufacturing

Gilead is the latest pharma company to announce that it’s pouring billions of dollars into its manufacturing and R&D operations in the US. The company said Wednesday that it’s investing a ...

FDA plans to expand unannounced inspections of foreign drug plants  - Pharmaceutical Technology

This move comes a day after President Trump signed an executive order to streamline approval processes for domestic plants.

Can the FDA Speed Up Drug Factory Construction? Trump’s Order Aims to Make It Happen

U.S. President Donald Trump signed an executive order aimed at accelerating the approval process for domestic pharmaceutical manufacturing facilities. The order instructs the Food and … Can the FDA Speed Up Drug Factory Construction? Trump’s Order Aims to Make It Happen Read More » The post Can the FDA Speed Up Drug Factory Construction? Trump’s Order Aims to Make It Happen first appeared on GeneOnline News. The post Can the FDA Speed Up Drug Fa…